PSEN1 loss-of-function variants do not cause early-onset Alzheimer's disease
PSEN1 variants are the most common cause of familial early-onset Alzheimer's disease (EOAD), but it is debated whether they act through a loss- or gain-of-function. Following a recent report of a duo with EOAD carrying a predicted loss-of-function (LoF) stop-gain variant (p.K109*) in PSEN1 , we sought to determine whether PSEN1 LoF variants, as a class, cause EOAD. We identified 45 carriers of PSEN1 LoF variants predicted to trigger nonsense-mediated decay in the Alzheimer's Disease Sequencing Project, UK Biobank, and BioVU databases. None of these carriers had a recorded case of early-onset dementia, and 17 were older than 65 years at last follow-up with no dementia or AD reported. Re-analysis of the reported AD-associated variant p.K109* revealed a cryptic splice site predicted to produce an in-frame deletion of 5 amino acids (p.K109_L113del). These results suggest that PSEN1 variants must produce an altered PSEN1 protein product to cause EOAD, while true null LoF PSEN1 alleles do not cause EOAD.
Authors
- Alex G. Contreras
- Yann Le Guen (ORCID: https://orcid.org/0000-0001-6649-8364)
- Amelia Farinas (ORCID: https://orcid.org/0000-0002-6697-8883)
- Michael D. Greicius (ORCID: https://orcid.org/0000-0002-5462-9037)
- Tanner D. Jensen (ORCID: https://orcid.org/0000-0002-1873-8607)
- Andrés Peña‐Tauber (ORCID: https://orcid.org/0000-0001-9501-4920)
- Paul M. Thompson (ORCID: https://orcid.org/0000-0002-4720-8867)
Institutions
- Vanderbilt University (US)
- Stanford University (US)
Publication Details
- Journal
- medRxiv
- Published
- 2026-11-13
- DOI
- https://doi.org/10.64898/2026.11.13.26367865
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- preprint